Lataa...
AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
BACKGROUND: Bone metastasis is one of the most common complications in clinical intractable castration-resistant prostate cancer (CRPC) and advanced prostate cancer period. The invasion ability of cancer cells was thought to have important relationship with the potential of cancer metastasis. EP4 re...
Tallennettuna:
| Julkaisussa: | Transl Androl Urol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5565529/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.s065 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|